- $55.54m
- -$38.63m
- 24
- 44
- 11
- 16
Annual cashflow statement for Rallybio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.6 | -26.4 | -47 | -66.7 | -74.6 |
| Depreciation | |||||
| Non-Cash Items | 0.441 | 2.23 | 5.15 | 10.1 | 9.87 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.07 | 2.12 | -3.78 | -0.936 | 4.28 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -15 | -22 | -45.5 | -57.3 | -60.3 |
| Capital Expenditures | -0.188 | -0.137 | -0.333 | -0.054 | -0.012 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -1.94 | -2 | -112 | 27.7 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.188 | -2.07 | -2.33 | -112 | 27.7 |
| Financing Cash Flow Items | -0.033 | -0.319 | -3.23 | -0.693 | -0.139 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 31.6 | 145 | 83 | 51.1 | 0.143 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.4 | 121 | 35.1 | -118 | -32.5 |